Hyunwon Yang

Prof. Hyunwon Yang

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2014 in Development and Reproduction
Verified
Journal Article
Open access
PDF file
JKJinhee Kim
Jinhee Kim
YCYiwa Chung
Yiwa Chung
HKHeejeong Kim
Heejeong Kim
EIEunji Im
Eunji Im
HLHyojin Lee
Hyojin Lee
HYHyunwon Yang
Hyunwon Yang
Nucleobindin protein, which was first identified in human and mouse cell lines, has two isotypes: nucleobindin 1 (NUCB1) and nucleobindin 2 (NUCB2) (Barnikol-Watanabe et al., 1994; Miura et al., 1992). However, NUCB2 only functions physiologically in humans and rodents (Miura et al., 1992). Nesfatin-1, nesfatin-2, and nesfatin-3 are generated through post-translational processing of NUCB2 via the enzyme pro-hormone convertase-1/3 (Gonzalez et al., 2010; Oh-I et al., 2006). A physiological activity has only been demonstrated for nesfatin-1 (Gonzalez et al., 2010). Nesfatin-1 is expressed in various hypothalamic nuclei for appetite control such as the arcuate nucleus (ARC), paraventricular nucleus (PVN), supraoptic nucleus (SO), lateral hypothalamic area (LHA), and zona incerta in rats (Brailoiu et al., 2007; Fort et al., 2008; García-Galiano et al., 2010; Goebel et al., 2009; Kohno et al., 2008). Nesfatin-1 also exists in cerebrospinal fluid and the brain stem, including the locus coeruleus, rostral raphe pallidus, Edinger-Westphal nucleus, and ventrolateral medulla (Goebel et al., 2009; Stengel et al., 2010). Intracerebroventricular infusion of nesfatin-1 decreases food intake and inhibits feeding behavior (Atsuchi et al., 2010; Shimizu et al., 2009), whereas infusion of a nesfatin-1-neutralizing antibody stimulates appetite (Oh-I et al., 2006).

1 December 2012 in Development and Reproduction
Verified
Journal Article
Open access
JKJinhee Kim
Jinhee Kim
HYHyunwon Yang
Hyunwon Yang
Nesfatin-1 is a recently discovered anorexigenic peptide which is distributed in several brain areas implicated in the feeding and metabolic regulation. Recently, it has been reported that nesfatin-1 is expressed not only in brain, but also in peripheral organs such as digestive organs, adipose tissues, heart, and reproductive organs. Nesfatin-1 is markedly expressed in the pancreas, stomach and duodenum. Eventually, the nesfatin-1 expression in the digestive organs may be regulated by nutritional status, which suggests a regulatory role of peripheral nesfatin-1 in energy homeostasis. Nesfatin-1 is also detected in the adipose tissues of humans and rodents, indicating that nesfatin-1 expression in the fat may regulate food intake independently, rather than relying on leptin. In addition, nesfatin-1 is expressed in the heart as a cardiac peptide. It suggests that nesfatin-1 may regulate cardiac function and encourage clinical potential in the presence of nutrition-dependent physio-pathologic cardiovascular diseases. Currently, only a few studies demonstrate that nesfatin-1 is expressed in the reproductive system. However, it is not clear yet what function of nesfatin-1 is in the reproductive organs. Here, we summarize the expression of nesfatin-1 and its roles in brain and peripheral organs and discuss the possible roles of nesfatin-1 expressed in reproductive organs, including testis, epididymis, ovary, and uterus. We come to the conclusion that nesfatin-1 as a local regulator in male and female reproductive organs may regulate the steroidogenesis in the testis and ovary and the physiological activity in epididymis and uterus.

10 January 2023 in Cells
Verified
Journal Article
Open access
PDF file
JPJi-Hye Park
Ji-Hye Park
JMJAE KYUNG MYUNG
JAE KYUNG MYUNG
SLSun-Joo Lee
Sun-Joo Lee
HKHyewon Kim
Hyewon Kim
SKSoyeon Kim
Soyeon Kim
MKMin-Jung Kim
Min-Jung Kim
Papillary thyroid cancer (PTC) is the most prevalent histological type of thyroid cancer (TC) worldwide. Although tumor metastasis occurs in regional lymph nodes, distant metastasis (DM) may also occur. Radioactive iodine (RAI) therapy is an effective treatment for TC; however, resistance to RAI occurs in patients with DM. Therefore, in this study, we investigated the efficacy of DM-related biomarkers as therapeutic targets for PTC therapy. ABCA1 expression was higher in aggressive BCPAP cells than in other PTC cells in terms of migration and invasion capacity. The knockdown of ABCA1 substantially decreased the expression of the epithelial–mesenchymal transition (EMT) marker, N-cadherin, and EMT regulator (ZEB1), resulting in suppressed migration and invasion of BCPAP cells. ABCA1 knockdown also reduced ERK activity and Fra-1 expression, which correlated with the effects of an ERK inhibitor or siRNA-mediated inhibition of ERK or Fra-1 expression. Furthermore, ABCA1-knocked-down BCPAP cells suppressed cell migration and invasion by reducing Fra-1 recruitment to Zeb1 promoter; lung metastasis was not observed in mice injected with ABCA1-knocked-down cells. Overall, our findings suggest that ABCA1 regulates lung metastasis in TC cells.

1 January 2015 in Peptides
Verified
Journal Article
Closed access
YCYiwa Chung
Yiwa Chung
JKJinhee Kim
Jinhee Kim
EIEunji Im
Eunji Im
HKHeejeong Kim
Heejeong Kim
HYHyunwon Yang
Hyunwon Yang

1 June 2019 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
JKJinhee Kim
Jinhee Kim
SSSojung Sun
Sojung Sun
DLDarae Lee
Darae Lee
HYHeejeong Youk
Heejeong Youk
HYHyunwon Yang
Hyunwon Yang

31 March 2017 in Development & Reproduction
Verified
Journal Article
Open access
PDF file
SSSojeong Seon
Sojeong Seon
DJDaun Jeon
Daun Jeon
HKHeejeong Kim
Heejeong Kim
YCYiwa Chung
Yiwa Chung
NCNarae Choi
Narae Choi
HYHyunwon Yang
Hyunwon Yang
Nucleobindin precursor protein, which was identified for the first time in the human and mouse cell lines, is known to have two isotypes, nucleobindin 1 (NUCB1) and nucleobindin 2 (NUCB2) (Miura et al., 1992; Kanai & Tanuma, 1992; Barnikol-Watanabe et al., 1994). However, NUCB2 only functions physiologically in humans and rodents (Miura et al., 1992). NUCB2 produces nesfatin-1 (residues 1-82), nesfatin-2 (residues 85-163), and nesfatin-3 (residues 166-396) by the enzyme pro-hormone convertase (PC)-1/3 after putative post-translational processing. Until now, a physiological activity has only been demonstrated for nesfatin-1 (Oh-I et al., 2006; Stengel et al., 2012).